Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome.
about
Pharmacological interventions for cognitive decline in people with Down syndromePharmacological interventions for cognitive decline in people with Down syndromeA genetic cause of Alzheimer disease: mechanistic insights from Down syndromeEffects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association studyThe effects of aging on the BTBR mouse model of autism spectrum disorder.Alzheimer's disease risk genes and the age-at-onset phenotype.Is Apolipoprotein E4 an Important Risk Factor for Dementia in Persons with Down Syndrome?"Down syndrome: an insight of the disease"Candidate genes for Alzheimer's disease are associated with individual differences in plasma levels of beta amyloid peptides in adults with Down syndrome.Integrated miRNA and mRNA expression profiling in fetal hippocampus with Down syndrome.Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome.Design and Synthesis of New Dual Binding Site Cholinesterase Inhibitors: in vitro Inhibition Studies with in silico DockingThe Role of PICALM in Alzheimer's Disease.A Review of Biomarkers for Alzheimer's Disease in Down SyndromeIs there a significant interaction effect between apolipoprotein E rs405509 T/T and ε4 genotypes on cognitive impairment and gray matter volume?Epidemiology of estrogen and dementia in women with Down syndrome.A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.Candidate gene analysis for Alzheimer's disease in adults with Down syndrome.Dysregulation of Rab5-Mediated Endocytic Pathways in Alzheimer's Disease.
P2860
Q24186316-2B905563-01C6-4EFA-A2CC-328AF4DE3FC7Q24188311-325AABFE-3072-4860-8EF5-161EED231A8BQ26798983-64172900-BD52-45B9-B05E-DDC42BE6ABE1Q30459046-6DF55E96-BA89-495F-9B69-7DB577AF939CQ30586703-BB5B8173-F5E6-4997-AC6A-44A23C5005E6Q33685232-B6FE5C5C-C369-474F-8D69-05F860B66550Q34917679-D1649CF9-ACEE-4F9A-9527-E7F8DA0891CBQ35730155-40CCF4D0-6186-49A4-88ED-FBA0D7AABD92Q36037548-C6CF1EDD-6F2A-4D43-8192-84DECAF79117Q36980997-34B6CEB3-4E69-4226-A000-5D6E56B40EFCQ37671444-5964AE4B-B42E-460B-B7B4-E7DEE7512D74Q37688131-21AB9C28-3D67-4ABA-8C04-FD1B98845049Q38245888-3B3914AB-AC7F-4380-B83C-5E2342B35B8BQ38653406-3A8DF6EE-F68E-4DBE-9026-F7139D139355Q39711376-7D5A9189-4F61-4B28-BDB5-79E0BF70D115Q40069328-8EA720A3-39EA-4391-B102-3665A1336DD1Q40154608-BB9D52DF-643F-419E-AE3B-F2BCAF20937BQ40181936-D785B86C-D11B-4B06-868B-52F79F3CEBBBQ47875216-782CD11A-DFEE-46B9-8709-5C0C0035CD2F
P2860
Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome.
@en
Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome.
@nl
type
label
Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome.
@en
Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome.
@nl
prefLabel
Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome.
@en
Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome.
@nl
P2093
P2860
P50
P1476
Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome.
@en
P2093
Emma L Jones
Julie Williams
Marisa Hanney
Rebecca Sims
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2013.03.018
P577
2013-04-18T00:00:00Z